Lupus
Rheumatology patients report 'substantial' treatment changes during height of COVID-19
The height of the COVID-19 pandemic in New York caused “substantial” medication changes for rheumatology patients in order to minimize infection risk and potential harm, according to findings published in Arthritis Care & Research.
Lupus Foundation of America: Patients remain 'at the heart of everything we do'
A complex autoimmune disease like lupus requires multi-pronged, multifactorial approaches for both individual patient management and for broader research and advocacy initiatives. It is difficult to diagnose, treat, and study in clinical trials.
Hydroxychloroquine fails to prevent COVID-19 in patients with rheumatic disease
Hydroxychloroquine fails to prevent COVID-19 among adults with rheumatoid arthritis, systemic lupus erythematosus or other related diseases, according to data published in The Lancet Rheumatology.
‘Low-cost, clinic-based intervention’ curtails hospital readmission rates in lupus
A multidisciplinary post-discharge intervention aimed at reducing 30-day hospital readmission rates among patients with systemic lupus erythematosus is feasible, but more data is needed to determine if it is effective, according to researchers.
In lupus, hydroxychloroquine blood levels matter more than dosage
Rheumatologists treating patients with systemic lupus erythematosus should focus more on hydroxychloroquine blood levels than on prescribed dosage based on weight, according to a speaker at the 2020 Congress of Clinical Rheumatology-West.
Grouping SLE subsets by symptoms may help patients 'proactively manage their disease'
Grouping patients with systemic lupus erythematosus into subsets based on inflammatory and noninflammatory symptoms may help them better understand their disease and treatment, according to a speaker at the 2020 Congress of Clinical Rheumatology-West.
Clinicians must account for myriad environmental factors when managing lupus
Understanding the interplay between environmental, genetic and other factors is critical to lupus management, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.
Smoking status, antimalarial use heavily influence cancer risk in SLE
Cancers — particularly lung cancer — were more likely to occur among patients with systemic lupus erythematosus who smoked, whereas use of antimalarials was linked to lower cancer risk, researchers noted.
List of drugs that may induce lupus erythematosus grows
Many drugs can induce cutaneous or systemic lupus erythematosus, and physicians should be aware of the evolving drug association list, according to a study.
Belimumab plus standard therapy superior to standard therapy alone for lupus nephritis
A 2-year randomized controlled trial has found that belimumab plus standard therapy is superior to standard therapy alone in patients with lupus nephritis, according to data published in the New England Journal of Medicine.